EA
LJPC

Emerald Acquisition’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Emerald Acquisition’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$726K Buy
+30,502
New +$575K ﹤0.01% 2282

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Acquisition's LJPC Position: Q3 2016 in Review

Emerald Acquisition opened a new position in La Jolla Pharmaceutical Company (LJPC) in Q3 2016: 30,502 shares worth $726K. The stake represents ﹤0.01% of the portfolio and ranks #2282 among its holdings.

71 funds tracked by Wall St. Rank hold LJPC as of Q3 2016.

  • Emerald Acquisition held 30,502 shares of La Jolla Pharmaceutical Company worth $726K as of Q3 2016.
  • La Jolla Pharmaceutical Company was a new Emerald Acquisition position in Q3 2016.
  • La Jolla Pharmaceutical Company made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2282 holding.
  • 71 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.